» Authors » Asako Ochiai

Asako Ochiai

Explore the profile of Asako Ochiai including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 206
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fukui-Watanabe Y, Suzuki M, Ochiai A, Ashizawa K, Saeki H, Naito T
IDCases . 2025 Feb; 39:e02154. PMID: 39906572
A 30-year-old woman presented with infertility and irregular menstruation. Physical examination revealed obesity and slightly pale conjunctivae. Transvaginal ultrasound revealed polycystic ovary, bilateral hydrosalpinx, and endometrial thickening. Magnetic resonance imaging...
2.
Murakami K, Kitade M, Kumakiri J, Takeuchi S, Kawasaki Y, Ochiai A, et al.
J Obstet Gynaecol Res . 2024 Sep; 50(11):2131-2137. PMID: 39318245
Aim: Studies on parasitic myomas after laparoscopic morcellation are mainly limited to case reports, and the incidence and risk factors have not yet been well-understood. We aimed to clarify the...
3.
Kuroda K, Matsumoto A, Horikawa T, Takamizawa S, Ochiai A, Kawamura K, et al.
Reprod Med Biol . 2023 Jan; 22(1):e12498. PMID: 36704119
Purpose: To clarify the mechanisms of intrauterine platelet-rich plasma (PRP) infusion that support embryo implantation in in vitro fertilization treatment. Methods: Blood and endometrial samples were collected from four infertile...
4.
Tamura N, Murakami K, Ozaki R, Takeuchi S, Ochiai A, Kawasaki Y, et al.
J Obstet Gynaecol Res . 2023 Jan; 49(3):1007-1011. PMID: 36631946
Aim: Even though 95% of struma ovarii are benign, it is often overtreated because of the difficulty to distinguish it from malignancy. In this study, our aim was to evaluate...
5.
Kuroda K, Nakagawa K, Horikawa T, Moriyama A, Ojiro Y, Takamizawa S, et al.
Am J Reprod Immunol . 2021 Apr; 86(3):e13429. PMID: 33835626
Problem: We aimed to assess whether an imbalance of T-helper (Th) 1 and Th2 cells contributes to implantation failure and pregnancy loss. Method Of Study: In this cross-sectional study, 197...
6.
Kuroda K, Matsumura Y, Ikemoto Y, Segawa T, Hashimoto T, Fukuda J, et al.
Am J Reprod Immunol . 2020 Nov; 85(5):e13376. PMID: 33166020
Problem: What are the pregnancy outcomes after the OPtimization of Thyroid function, Immunity, and Uterine Milieu (OPTIMUM) treatment strategy in patients with repeated implantation failure (RIF)? Method Of Study: Infertile...
7.
Kuroda K, Nagai S, Ikemoto Y, Matsumura Y, Ochiai A, Nojiri S, et al.
Reprod Biomed Online . 2020 Oct; 42(1):125-132. PMID: 33051135
Research Question: What are the risk factors affecting the incidences of moderate-to-severe ovarian hyperstimulation syndrome (OHSS) and severe hemoperitoneum in assisted reproductive technology (ART) treatment cycles? Design: A retrospective cohort...
8.
Kuroda K, Ochiai A, Brosens J
Biol Reprod . 2020 Oct; 103(6):1152-1156. PMID: 33029621
Resveratrol, a natural polyphenolic compound, is widely studied for its anti-inflammatory and antisenescent properties. Recently, two studies reported seemingly conflicting findings on the actions of resveratrol on decidualization of human...
9.
Tsunemi A, Uchida T, Kuroda K, Ikemoto Y, Ochiai A, Goto H, et al.
Endocr J . 2020 Oct; 68(2):171-177. PMID: 32999139
Recent randomized controlled studies have revealed that levothyroxine (LT4) treatment improves pregnancy outcomes only in infertile women with subclinical hypothyroidism who have thyroid autoantibodies (TAs), but not for those with...
10.
Ochiai A, Kuroda K
Reprod Med Biol . 2020 Apr; 19(2):107-113. PMID: 32273814
Background: Resveratrol is an antiaging, antioxidant, anti-inflammatory, and insulin-sensitizing natural polyphenolic compound. Growing evidence indicates that resveratrol has potential therapeutic effects in infertile women with diminished ovarian function, polycystic ovary...